The KRT6A gene helps make a keratin protein that gives strength to the skin, nails, and the lining of the mouth, especially in areas that face rubbing and pressure. If this gene does not work properly, these tissues may become fragile or may build up too much hard skin. Pathogenic variants in the KRT6A gene can cause pachyonychia congenita, a rare inherited skin condition that often leads to very thick nails, painful calluses on the soles of the feet, and sometimes white patches inside the mouth.
What is a gene?
Genes are sections of DNA that contain instructions your cells use to make molecules or regulate processes in the body. Some genes carry the information needed to produce proteins, the parts of cells that do much of the work. Other genes mainly help control when certain processes take place, where they occur, and how strongly they run. Together, genes influence the body’s development and function, and they can shape how you respond to food, stress, or medications. To explore this topic in more detail, you can learn more in the LearnHub.
Overview
KRT6AGene function
What if the gene works
The KRT6A gene helps make a keratin protein that strengthens skin, nails, and the lining of the mouth. It is especially active in areas that face friction and helps tissues handle everyday wear.
Risk
What if the gene does not work
Pathogenic variants in the KRT6A gene most often cause pachyonychia congenita, with thick nails and painful thickened skin on the soles. Milder or more severe variants can affect when symptoms appear and how noticeable they are.
Treatment
What does that mean for your treatment
No KRT6A-specific treatment or management approach is currently established. Care is still based on easing symptoms and reducing pressure on affected skin and nails. The KRT6A gene is being studied as a treatment target in pachyonychia congenita, including early work on variant-specific RNA therapies.
Conditions associated with KRT6A
Gene function
What if the gene works
Everyday rubbing from walking, chewing, and using your hands puts constant strain on surface tissues. The KRT6A gene helps certain skin, nail, and mouth lining cells stay strong during that wear. Understanding what the KRT6A gene does in skin and nails helps explain how these tissues keep their shape and bounce back as they renew.
Inside surface cells, the KRT6A gene helps build tough protein strands made of keratin. These strands form an inner framework that helps cells keep their shape during daily movement and pressure.
Its protein joins with other keratin proteins to create a flexible support network inside the cell. This network helps skin and related tissues handle rubbing, stretching, and repeated minor stress.
KRT6A activity is strongest in tissues that face regular wear, including the palms, soles, nail areas, and the lining of the mouth. This helps these surfaces stay resilient while they act as protective coverings.
When outer tissues are renewing after normal wear, cells can increase KRT6A production as they stay active. This supports the steady rebuilding that keeps the surface layer durable.
What is a variant?
A genetic variant is a small difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, such as variation in appearance, metabolism, or how the body responds to environmental factors. Many variants do not cause any noticeable effect and simply reflect natural genetic variation. In some situations, though, a variant can change how a gene functions more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Most disease-causing variants in the KRT6A gene are missense changes, so cells make an altered keratin 6A protein. These KRT6A gene variants can disrupt protein folding and the joining of keratin strands into the tough support fibers inside skin cells, letting the abnormal protein weaken the whole network. Milder variants may leave some function intact, while more disruptive variants often have a stronger effect and can be linked to earlier or more marked features of pachyonychia congenita.
How variants are linked to conditions
Pathogenic variants in the KRT6A gene cause KRT6A-related pachyonychia congenita, a rare inherited skin condition. In studies of KRT6A gene variants and pachyonychia congenita, common features include thick, painful skin on the soles and palms, thickened nails, and sometimes white patches in the mouth or small cysts. Symptoms can vary from person to person, including within the same family.
A variant is not necessarily a diagnosis
Genetic variants are a common and expected part of human biology in the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a confirmed diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For KRT6A, risk is mainly set by whether someone carries a disease-causing gene change, and symptoms often begin early in life. Day-to-day severity can be made worse by repeated pressure and friction on the feet, such as long walks, running, or tight shoes. There is not enough evidence to say that specific lifestyle changes lower the underlying genetic risk.
Inheritance of KRT6A variants
Variants in the KRT6A gene are usually inherited in an autosomal dominant pattern, which means a child can inherit the condition if just one parent carries the variant. In practical terms, the KRT6A inheritance pattern gives each child a 50% chance of inheriting that variant from an affected parent. Some people have a new, de novo variant in the KRT6A gene, meaning it started in them and was not inherited from either parent.
What does my KRT6A result mean for my family?
A disease-causing change in the KRT6A gene is usually passed down in a dominant pattern, so close relatives such as a parent, child, brother, or sister may also carry the same change and may have similar nail or skin symptoms. Each child of someone with a KRT6A-related condition has a 1 in 2, or 50%, chance of inheriting it. Some cases happen for the first time in one family, so a parent is not always the source.
Genetic information
Genetic testing
How you find out about variants
Genetic testing for KRT6A variants usually uses a blood sample or cheek swab to read the KRT6A gene and look for changes linked to inherited nail and skin conditions. Results can confirm whether a variant is present, help clarify a diagnosis, and sometimes show whether other family members may carry the same change.
When should I consider getting a genetic test?
Consider testing for changes in the KRT6A gene if you or your child has very thick nails, painful hard skin on the feet, or a family history of pachyonychia congenita. A genetic test can help confirm the cause of these symptoms and clarify whether other relatives may also carry the same change.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but the amount it explains varies with the condition and the kind of variant found. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information offers context rather than certainty and is most helpful when viewed with the rest of a person's care. In other situations, a genetic result can give a clear answer. For medication response, it can also help put personal experiences in context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. This helps explain why the same treatment may work well for one person, have less effect in another, or cause more side effects in someone else. Differences in how the body absorbs, breaks down, and responds to a drug are common, and genes are one part of that picture alongside age, other health conditions, and other medicines.
What is Pharmacogenetics?
Pharmacogenetics is the area of study that examines how genetic differences can shape a person’s response to medications. It looks at relationships between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes affect how strongly a drug works or how the body handles it. This information can support more informed, more personalized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the KRT6A gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose, so questions about medicines, side effects, or new health concerns are best discussed with your doctor.
History
Doctors first recognized the nail and skin changes now linked to the KRT6A gene long before the gene itself was identified. Inheritance patterns were noticed long before the gene was identified. During the late 20th century, researchers mapped several keratin genes and showed that different family patterns of pachyonychia congenita were tied to specific genes rather than one single cause. This led to the KRT6A gene being established as one of the main genes involved in the condition. Over time, descriptions became more precise as genetic testing replaced diagnosis based only on appearance. That shift helped families receive clearer answers and helped researchers organize pachyonychia congenita into more accurate genetic subtypes.